This post was authored by Pranav Puri, a first year undergraduate student at The University of Chicago.
Approximately 600,000 percutaneous coronary interventions (PCIs) are performed in the U.S. each year at a cost that exceeds $12 billion. In recent years, the emphasis of the national health care system has shifted towards providing higher quality care at lower costs, and payment models are shifting away from fee-for-service towards population-based health management and bundled payments. In an effort to assist both physicians and patients in choosing the best procedure for patient outcomes, the ACC developed appropriate use criteria (AUC) for coronary revascularization in 2009 and released a focused update in January 2012.
In February 2012, UnityPoint Trinity in Rock Island, IL initiated a process involving the education and participation of physicians and nurses towards the implementation of the ACC’s AUC. Since the economic impact of AUC has been of interest to me for quite some time (read my previous blog on my poster presentation at ACC.13 here), my colleagues and I put together a study to assess the long-term effects of implementation of AUC on volumes of both interventions and diagnostics. We also studied the distribution of acute vs. elective interventions, and aimed to quantify the economic impact of implementation of the AUC. Continue reading →
This post was authored by Robert A. Shor, MD, FACC, chair of ACC’s Board of Governors.
What is the ACC’s Board of Governors (BOG) and why should I care?
It is a privilege to serve as chair of the BOG this year. It is my mission to highlight and emphasize the integral value that ACC Chapters and their leaders provide to cardiovascular professionals across the U.S. and to ensure the goals of ACC’s state chapters also align with the College’s strategic plan. To begin, we must start at the very beginning – what are ACC Chapters? Who leads them? What do these leaders do? Continue reading →
This post was authored by Valentin Fuster, MD, PhD, Editor-in-Chief of JACC.
Dr. William W. Parmley was a pioneer for all cardiovascular researchers, and I feel proud that JACC continues to honor his legacy by recognizing two up-and-coming investigators, as well as their mentors and institutional research programs through this prestigious award each year.
This year, we honor two young researchers working in areas of great clinical interest:
Muralidhar Padala, PhD, from Emory University
Mentor: Robert Guyton, MD
Manuscript: “Temporal Changes in Interpapillary Muscle Dynamics as an Active Indicator of Mitral Valve and Left Ventricular Interaction in Ischemic Mitral Regurgitation in Humans,” published in the November 4 issue of JACC
Pablo Martínez-Legazpi, MEng, PhD, from Hospital Gregorio Maranon/University of California, San Diego
Mentors: Javier Bermejo, MD, PhD & Juan C. del Álamo, AeEng, PhD
Manuscript: “Contribution of the Diastolic Vortex Ring to Left Ventricular Filling,” published in the October 21 issue of JACC
As the San Diego sun sets on ACC.15, I am excited to follow in the footsteps of my friend Patrick T. O’Gara, MD, MACC, and the many others who have come before me, to serve as ACC president.
It’s been an incredible last three days of innovation, networking and practice-shaping research – made all the more successful by the enthusiasm and participation of the more than 13,500 attendees from quite literally around the world.
Dr. O’Gara kicked off the meeting by imploring us to take advantage of the opportunity afforded by ACC.15 to expand our knowledge base, generate new insights and forge connections across ideas and shared goals. From what I witnessed, ACC.15 attendees rose to this challenge. Continue reading →
See more insightful interviews on the hottest topics and Late-Breaking Clinical Trials from the last day of ACC.15. For comprehensive coverage of the meeting from the fellow perspective, see the full list of FITs on the GO videos on visit the ACC’s FITs on the Go YouTube Playlist. Highlights from the third day include:
This post was authored by John Gordon Harold, MD, MACC, past president of the ACC.
It is my privilege and honor to chair a session today on the critical topic of “Population & Global Health – Combating CV Diseases/Non-Communicable Diseases (NCDs) Globally.” The session is part of the special Future of Cardiovascular Medicine Track, which is focused on what the world will look like in 2025 in the context of cardiovascular health. The first United Nations High-level Meeting on NCDs in 2011 led to the adoption of the UN Political Declaration which placed NCDs on the global health and development agenda. Member States committed to a set of actions to accelerate the NCD response. I had the privilege of attending the United Nations deliberations on NCDs in June 2014 and testifying before the General Assembly. Given the lofty global goal of the United Nations and World Health Organization to reduce premature mortality from NCDs by 25 percent by 2025, this session couldn’t be more pertinent. As Dr. Margaret Chan (Director-General of the World Health Organization) has been quoted “A world that is greatly out of balance in matters of health is neither stable nor secure.” Continue reading →
This post was authored by Jeffrey S. Soble, MD, FACC.
The ACC recently embarked on a partnership with global incubator and investment fund, 1776, to help fuel innovation in health care. As part of this partnership, the College is supporting the 1776 Challenge Cup, a global competition to identify the most promising startups solving some of the world’s biggest challenges, including health care.
Challenge Cup winner Tal Givoly of Medivizor.
As part of this support, the ACC is hosting several of the health care Challenge Cup winners from around the globe in San Diego for ACC.15. It’s been a privilege to interact with these innovative start-up founders and learn first-hand from them about the challenges and opportunities associated with bringing innovation to life. Over the last three days, Challenge Cup winners have attended sessions in the Future of CV Medicine pathway, met with industry representatives and networked with ACC leaders. Continue reading →
This post was authored by Sanjeev Bhavnani, MD, chair of the ACC.15 session on Mobile Technology in Health Care.
On day one of the Future of Cardiovascular MedicineTrack at #ACC15, we experienced innovation in several forms – most of all among our participants who were actively tweeting, texting and engaging to convey their thoughts and comments through social media and virtual connections. Cardiology has always been strongest at its roots and if this is an example of the things to come, we are well positioned for the future. Continue reading →
2015 ACC/Merck Fellows Adam Castano, MD and Amit Khera, MD (not pictured: Sandeep Krishnan, MD and Meagan Wasfy, MD)
Winners of the 2015 ACC/Merck Fellowship Program were recognized Saturday evening by leaders from the ACC and Merck. This unique program has provided generous support to four fellows in training (FITs) seeking to launch careers in cardiovascular research. In selecting applications, proposals addressing cardiovascular disease and cardiometabolic disorders are encouraged, and preference for one award is given to applicants focusing on disparities of care.The selected FITs are provided with $70,000 to support research in adult cardiology. Congratulations to this year’s winners: Continue reading →